Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D02EHE
|
|||
| Drug Name |
BI-730357
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Plaque psoriasis [ICD-11: EA90.0; ICD-10: L40.0; ICD-9: 696] | Phase 2 | [1] | |
| Company |
Boehringer Ingelheim
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03835481) A Study to Test How Well Patients With Plaque Psoriasis Tolerate BI 730357 Over a Longer Period and How Effective it is. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.